News >

Novel BISCAY Trial Looks Toward Future of Bladder Cancer Treatment

Jessica Hergert
Published: Wednesday, Oct 23, 2019

Thomas Powles, MD, MBBS, MRCP, professor of genitourinary oncology, lead, Solid Tumor Research, director, Barts Cancer Center, in London, England

Thomas Powles, MD, MBBS, MRCP

Results of the biomarker-driven phase Ib BISCAY trial, while it did not meet the prespecified efficacy target, led to intriguing questions about possible future treatment options for patients with metastatic urothelial cancer, explained Thomas Powles, MD, MBBS, MRCP.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication